| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |